Patient-derived joint counts are a potential alternative for determining disease activity score

Journal of Rheumatology

Volumn 37, Issue 5, 2010, Pages 1035-1041

  Kavanaugh, Arthur ^a   Lee, Susan J ^b   Weng, Haoling H ^c   Chon, Yun ^c   Huang, Xing Yue ^c   Lin, Shao Lee ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMGEN INC   (United States)

Author keywords

Disease activity score; Etanercept; Eular response; Patient reported outcomes; Rheumatoid arthritis

Indexed keywords

ETANERCEPT; METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; FEMALE; HUMAN; IMMUNOGENICITY; JOINT; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PHYSICIAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN G; JOINTS; MALE; METHOTREXATE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICAL EXAMINATION; QUESTIONNAIRES; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; SYNOVITIS; TREATMENT OUTCOME;

EID: 77951770086     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090704     Document Type: Article

References (21)

1. Wolfe F, Cush JJ, O'Dell JR, Kavanaugh A, Kremer JM, Lane NE, et al. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 2001;28:1423-1430 (Pubitemid 32510520)
2. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9.
3. van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-920
4. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-48
5. van der Heijde DM, van 't Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992;51:177-181
6. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-2017
7. Dore RK, Mathews S, Schechtman J, Surbeck W, Mandel D, Patel A, et al. The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin Exp Rheumatol 2007;25:40-46 (Pubitemid 46477484)
8. Scott DL, van Riel PL, van der Heijde D, Benke AS. Assessing disease activity in rheumatoid arthritis. The EULAR handbook of standard methods. Vienna: European League Against Rheumatism; 1993.
9. Houssien DA, Stucki G, Scott DL. A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research. Rheumatology 1999;38:48-52. (Pubitemid 29509656)
10. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-1850
11. DAS-Score.NL. Nijmegen, The Netherlands: Department of Rheumatology, University Medical Center; 2009. [Internet. Accessed January 7, 2010.] Available from: http://www.das-score.nl/ www.das-score.nl
12. Cole JC, Motivala SJ, Khanna D, Lee JY, Paulus HE, Irwin MR. Validation of single-factor structure and scoring protocol for the Health Assessment Questionnaire-Disability Index. Arthritis Rheum 2005;53:536-542 (Pubitemid 41278918)
13. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-145
14. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.
15. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003;42:244-257 (Pubitemid 36305610)
16. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-374
17. Hanly JG, Mosher D, Sutton E, Weerasinghe S, Theriault D. Self-assessment of disease activity by patients with rheumatoid arthritis. J Rheumatol 1996;23:1531-1538 (Pubitemid 26290577)
18. Levy G, Cheetham C, Cheatwood A, Burchette R. Validation of patient-reported joint counts in rheumatoid arthritis and the role of training. J Rheumatol 2007;34:1261-1265 (Pubitemid 46898106)
19. Figueroa F, Braun-Moscovici Y, Khanna D, Voon E, Gallardo L, Luinstra D, et al. Patient self-administered joint tenderness counts in rheumatoid arthritis are reliable and responsive to changes in disease activity. J Rheumatol 2007;34:54-56 (Pubitemid 46106562)
20. Scott DL, Choy EH, Greeves A, Isenberg D, Kassinor D, Rankin E, et al. Standardising joint assessment in rheumatoid arthritis. Clin Rheumatol 1996;15:579-582 (Pubitemid 26405573)
21. Rau R, Herborn G, Menninger H, Sangha O. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology 2002;41:196-204.